About
MediTulip develops patented medical devices including an asymmetrical endoscopic linear stapler that allows pathological confirmation of cancer cells on resection margins and the TULIP PORT, an implantable chemoport for safe and convenient injectable cancer treatments.
Explore MediTulip's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.